Catalyst Wire Dossier Catalyst Wire Dossier

VEGF inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VEGF inhibitor, covering 2014-10-16 to 2014-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer [Phase 2]

See pricing